Rapastinel

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Rapastinel topic overview

The analysis highlights History and Research as prominent areas in the source structure around Rapastinel.

Related topics: 50
Source areas: 5
Connected nodes: 55
Extracted relationships: 56
Concept neighborhoods: 22
Bridge connections: 55

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 18 topics

Preclinical research · 15 topics

Clinical development · 9 topics

Pharmacology · 5 topics

History · 3 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
ATC code: None
CAS Number: 117928-94-6 Y
ChemSpider: 25069944
CompTox Dashboard (EPA): DTXSID501030481
Drug class: Selective NMDA receptor modulator

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

INN International Nonproprietary Name
Antidepressant
Allergan
Naurex
Adjunctive therapy
Treatment-resistant depression
Centrally active Central nervous system
Intravenously Intravenous
Administered Drug administration
Orally active Oral administration
Amidated Amide
Tetrapeptide
Selective Binding selectivity
Modulator Receptor modulator
NMDA receptor
Cognitive enhancer
Signal transduction
Synaptic plasticity

Clinical development

Fast Track designation FDA Fast Track Development Program
Phase II Phases of clinical research
Proof of concept
HAM-D Hamilton Rating Scale for Depression
Breakthrough Therapy
Apimostinel
Analog Structural analog
Potency Potency (pharmacology)
Zelquistinel AGN-241751

Pharmacology

Preclinical research

History

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Rapastinel connects Entity context

The extracted context around Rapastinel shows recurring relationship patterns in the source. For example, Rapastinel → AGN-241751, Allergan, As, Breakthrough Therapy, Early, Fast Track, FDA, GATE-202, GATE-251, HAM-D, II, III, July, Naurex, NRX-1074, On January, On March Another extracted example is Rapastinel → CA1, CA3, In, It, Mongolian Gerbils, Neuroprotective, NMDA, NR1, Schaffer. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Clinical development · 17

Rapastinel → AGN-241751, Allergan, As, Breakthrough Therapy, Early, Fast Track, FDA, GATE-202, GATE-251, HAM-D, II, III, July, Naurex, NRX-1074, On January, On March

related to Preclinical research · 9

Rapastinel → CA1, CA3, In, It, Mongolian Gerbils, Neuroprotective, NMDA, NR1, Schaffer

related to External links · 7

Rapastinel → AdisInsightRapastinel, Allergan, GLYX-13, Inc, Naurex, Rapastinel Receives FDA Breakthrough, Therapy Designation

related to history · 4

Rapastinel → B6B21, Joseph Moskal, Naurex, NMDA

related to Pharmacology · 4

Rapastinel → At, NMDA, NMDAR-mediated, Positive

3D model (JSmol) · 1

Rapastinel → Interactive image

ATC code · 1

Rapastinel → None

CAS Number · 1

Rapastinel → 117928-94-6 Y

ChemSpider · 1

Rapastinel → 25069944

CompTox Dashboard (EPA) · 1

Rapastinel → DTXSID501030481

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

nmda receptor antidepressant development allergan naurex therapy novel glyx-13 drug effects adjunctive selective modulator clinical also name code fda designation

Rapastinel relationships Subject–Predicate–Object triples

TTTA extracted 56 structured relationships around Rapastinel. Examples in this analysis include Rapastinel → 3D model (JSmol) → Interactive image and Rapastinel → ATC code → None. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Rapastinel	3D model (JSmol)	Interactive image	1.00	infobox
Rapastinel	ATC code	None	1.00	infobox
Rapastinel	CAS Number	117928-94-6 Y	1.00	infobox
Rapastinel	ChemSpider	25069944	1.00	infobox
Rapastinel	CompTox Dashboard (EPA)	DTXSID501030481	1.00	infobox
Rapastinel	Drug class	Selective NMDA receptor modulator	1.00	infobox
Rapastinel	Formula	C18H31N5O6	1.00	infobox
Rapastinel	Legal status	US: Investigational New Drug	1.00	infobox
Rapastinel	Molar mass	413.475 g·mol−1	1.00	infobox
Rapastinel	Other names	GLYX-13; BV-102	1.00	infobox
Rapastinel	PubChem CID	14539800	1.00	infobox
Rapastinel	Routes of administration	Intravenous	1.00	infobox
Rapastinel	UNII	6A1X56B95E	1.00	infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Rapastinel bring nearby vocabulary together. In this analysis, examples include Receptor, Nmda and Therapy. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Rapastinel
- Receptor
- Nmda
- Therapy
- Designation
- Depression
- Glycine
- Investigational
- March
- Treatment-resistant
- Also
- Clinical
- Disorder
rapastinel
- Receptor
- Nmda
- Therapy
- Designation
- Depression
- Glycine
- Investigational
- March
- Treatment-resistant
- Also
- Clinical
- Disorder
antidepressant
- Effects
- Cognitive
- Enhance
- Rapid-acting
- Drug
- Development
- Nmda
- Rapastinel
- Code
- Depression
- Name
- Plasticity
clinical development
- Clinical
- Development
- Drug
- Depression
- Name
- Treatment-resistant
- Adjunctive
- Depressive
- Glyx-13
- Therapy
- Code
- Investigational
treatment-resistant depression
- Adjunctive
- Therapy
- Development
- Code
- Depression
- Name
- Treatment
- Treatment-resistant
- Clinical
- Depressive
- Designation
- Disorder
nmda receptor
- Receptor
- Rapastinel
- Glycine
- Selective
- Also
- Cognitive
- Plasticity
- Synaptic
- Drug
- Novel
- Tetrapeptide
- Investigational
nmda receptor antagonist
- Receptor
- Rapastinel
- Glycine
- Selective
- Also
- Cognitive
- Plasticity
- Synaptic
- Drug
- Novel
- Tetrapeptide
- Investigational
adjunctive therapy
- Designation
- Treatment
- Treatment-resistant
- Depressive
- Disorder
- Fda
- Therapy
- Development
- Code
- Depression
- Name
- Glyx-13

Connections between topic areas Semantic bridges

For Rapastinel, one of the stronger structural bridges in this analysis connects Rapastinel with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Rapastinel — Overview · splits 37 ⟂ 19

Rapastinel — Preclinical research · splits 40 ⟂ 16

Rapastinel — Clinical development · splits 46 ⟂ 10

Rapastinel — Pharmacology · splits 50 ⟂ 6

Rapastinel — History · splits 52 ⟂ 4

Map overview Semantic statistics

Rapastinel

Nodes56

Edges55

Triples56

Avg. degree1.96

Density0.035714

Components1

Source & methodology

TTTA analyzes the structure around Rapastinel to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Rapastinel · EN edition · Analysis: TopicsToTalkAbout